...provide its CRISPR enzyme MAD7 free of charge to researchers for R&D use. Inscripta (formerly Muse Biotechnology Inc....

...provide its CRISPR enzyme MAD7 free of charge to researchers for R&D use. Inscripta (formerly Muse Biotechnology Inc....

...On Feb. 28, genome engineering company Muse Biotechnology Inc. (Boulder, Colo.) raised $23 million in a series B...
...by Venrock. Foresite Capital and Paladin Capital participated, as did existing investors NanoDimension and Spruce/MLS. Muse Biotechnology Inc....

...Genome engineering company Muse Biotechnology Inc. (Boulder, Colo.) said it raised $23 million in an oversubscribed series B...